Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.65 |
| ▸ | GAA | P10253 | 2/20 | 0.65 |
| ▸ | NPC1 | O15118 | 2/20 | 0.65 |
| ▸ | RAB9A | P51151 | 2/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.63 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitric Acid SCHEMBL5739897 | 0.91 | ALDH1A1 (0.57) | ALDH1A1CYP2C9SMN1; SMN2GAANPC1 | |
| SCHEMBL3093813 | 0.87 | SMN1; SMN2 (0.70) | ALDH1A1CYP2C9SMN1; SMN2GAANPC1 | |
| SCHEMBL21233205 | 0.86 | ALDH1A1 (0.50) | ALDH1A1CYP2C9SMN1; SMN2GAANPC1 | |
| SCHEMBL1328541 | 0.85 | ALDH1A1 (0.51) | ALDH1A1CYP2C9SMN1; SMN2GAANPC1 | |
| SCHEMBL5660651 | 0.85 | ALDH1A1 (0.49) | ALDH1A1CYP2C9SMN1; SMN2GAANPC1 | |
| SCHEMBL15669005 | 0.84 | SMN1; SMN2 (0.67) | ALDH1A1CYP2C9SMN1; SMN2GAANPC1 | |
| SCHEMBL14398435 | 0.83 | ALDH1A1 (0.68) | ALDH1A1CYP2C9SMN1; SMN2GAANPC1 | |
| SCHEMBL2341793 | 0.83 | SMN1; SMN2 (0.65) | ALDH1A1CYP2C9SMN1; SMN2GAANPC1 | |
| SCHEMBL15669126 | 0.82 | ALDH1A1 (0.61) | ALDH1A1CYP2C9SMN1; SMN2GAANPC1 | |
| SCHEMBL15668691 | 0.82 | ALDH1A1 (0.61) | ALDH1A1CYP2C9SMN1; SMN2GAANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12528798-B2 | Compound for crop protectant | LG CHEM, LTD. (KR) | 2026-01-20 | — | — | US | disclosed |
| US-20240246945-A1 | NOVEL COMPOUND FOR CROP PROTECTANT | LG CHEM, LTD. (KR) | 2024-07-25 | — | — | US | disclosed |
| WO-2021086044-A1 | NOVEL COMPOUND FOR CROP PROTECTANT | 주식회사 엘지화학 | 2021-05-06 | — | — | WO | disclosed |
| EP-2914580-B1 | THIOARYL DERIVATIVES AS GPR120 AGONISTS | LG CHEMICAL LTD (KR) | 2019-02-20 | — | — | EP | disclosed |
| US-9447044-B2 | Thioaryl derivatives as GPR120 agonists | LG LIFE SCIENCES LTD. (KR) | 2016-09-20 | — | — | US | disclosed |
| US-20150291527-A1 | THIOARYL DERIVATIVES AS GPR120 AGONISTS | LG LIFE SCIENCES LTD. (KR) | 2015-10-15 | — | — | US | disclosed |
| EP-2914580-A1 | THIOARYL DERIVATIVES AS GPR120 AGONISTS | LG Life Sciences Ltd. (KR) | 2015-09-09 | — | — | EP | disclosed |
| WO-2014069963-A1 | THIOARYL DERIVATIVES AS GPR120 AGONISTS | LG LIFE SCIENCES LTD. (KR) | 2014-05-08 | — | — | WO | disclosed |
| US-8383855-B2 | Histone deacetylase inhibitors | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2013-02-26 | — | — | US | disclosed |
| US-8222423-B2 | Bifunctional histone deacetylase inhibitors | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2012-07-17 | — | — | US | disclosed |
| US-20060004052-A1 | Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy | AGOURON PHARMACEUTICALS, INC. | 2006-01-05 | — | — | US | disclosed |
| US-6967198-B2 | Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy | AGOURON PHARMACEUTICALS INC. (US) | 2005-11-22 | — | — | US | disclosed |
| EP-1585749-A1 | DIAZEPINOINDOLE DERIVATIVES AS KINASE INHIBITORS | PFIZER INC. (US) | 2005-10-19 | — | — | EP | disclosed |
| US-20050075499-A1 | Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy | AGOURON PHARMACEUTICALS, INC. | 2005-04-07 | — | — | US | disclosed |
| WO-2004063198-A1 | DIAZEPINOINDOLE DERIVATIVES AS KINASE INHIBITORS | PFIZER INC. (US) | 2004-07-29 | — | — | WO | disclosed |
| US-20040072849-A1 | Dioxanes and uses thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-04-15 | — | — | US | disclosed |
| US-20020115692-A1 | Tryptophan derivatives | CELLTECH R&D, LTD. (GB) | 2002-08-22 | — | — | US | disclosed |
| WO-2002042294-A1 | 1-SULFONYL SUBSTITUTED TRYPTOPHANE DERIVATIVES AND ITS USE AS INTEGRIN INHIBITORS | CELLTECH R & D LIMITED (GB) | 2002-05-30 | — | — | WO | disclosed |
| US-20020052295-A1 | Diacyl derivatives of propylene diamine having herbicidal activity | MONSANTO TECHNOLOGY LLC | 2002-05-02 | — | — | US | disclosed |
| WO-2001046152-A1 | HERBICIDAL DIACYL DERIVATIVES OF PROPYLENE DIAMINE | MONSANTO TECHNOLOGY LLC (US) | 2001-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060004052-A1 | Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy | CHEK1, CHEK2, CHKA | ALDH1A1 4205/4885CYP2C9 4233/4885SMN1; SMN2 3667/4885 |
| US-20150291527-A1 | THIOARYL DERIVATIVES AS GPR120 AGONISTS | GPR119, GLP1R, GCGR | ALDH1A1 1822/4885CYP2C9 1953/4885SMN1; SMN2 4477/4885 |
| US-20240246945-A1 | NOVEL COMPOUND FOR CROP PROTECTANT | KEAP1, BROX, GPX1 | ALDH1A1 2249/4885CYP2C9 3365/4885SMN1; SMN2 4025/4885 |
| US-20050075499-A1 | Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy | CHEK2, CHEK1, CHKA | ALDH1A1 4319/4885CYP2C9 4286/4885SMN1; SMN2 3537/4885 |
| US-20040072849-A1 | Dioxanes and uses thereof | UTS2R, HDAC5, AMDHD2 | ALDH1A1 682/4885CYP2C9 3821/4885SMN1; SMN2 3947/4885 |
| US-12528798-B2 | Compound for crop protectant | CBR1, CBR3, GSTO1 | ALDH1A1 2445/4885CYP2C9 2243/4885SMN1; SMN2 3114/4885 |
| US-20020115692-A1 | Tryptophan derivatives | IDO1, TPH1, IDO2 | ALDH1A1 103/4885CYP2C9 747/4885SMN1; SMN2 2691/4885 |
| US-20020052295-A1 | Diacyl derivatives of propylene diamine having herbicidal activity | DDT, SAT1, AOC1 | ALDH1A1 232/4885CYP2C9 614/4885SMN1; SMN2 4037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.